140 related articles for article (PubMed ID: 23641344)
41. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
42. Formulation and physicochemical characterization of buccoadhesive microspheres containing diclofenac sodium.
Jelvehgari M; Valizadeh H; Jalali Motlagh R; Montazam H
Adv Pharm Bull; 2014; 4(3):295-301. PubMed ID: 24754015
[TBL] [Abstract][Full Text] [Related]
43. Engineered microparticles based on drug-polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters.
Gavini E; Bonferoni MC; Rassu G; Sandri G; Rossi S; Salis A; Porcu EP; Giunchedi P
Drug Dev Ind Pharm; 2016; 42(4):554-62. PubMed ID: 26482534
[TBL] [Abstract][Full Text] [Related]
44. Pre-exposure prophylactic mucoadhesive sodium alginate microsphere laden pessaries for intravaginal delivery of tenofovir disoproxil fumarate.
Avlani D; Shivakumar HN; Kumar A; Prajila A; Baraka BBH; Bhagya V
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128816. PubMed ID: 38114000
[TBL] [Abstract][Full Text] [Related]
45. Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3).
Bakhteyar H; Cassone C; Kohan HG; Sani SN
Int J Pharm Compd; 2017; 21(5):418-425. PubMed ID: 29216618
[TBL] [Abstract][Full Text] [Related]
46. Development and in vitro evaluation of diclofenac sodium loaded mucoadhesive microsphere with natural gum for sustained delivery.
Amin ML; Jesmeen T; Sutradhar KB; Mannan MA
Curr Drug Deliv; 2013 Dec; 10(6):765-70. PubMed ID: 23937160
[TBL] [Abstract][Full Text] [Related]
47. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
Rajinikanth PS; Karunagaran LN; Balasubramaniam J; Mishra B
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1658-64. PubMed ID: 19043235
[TBL] [Abstract][Full Text] [Related]
48. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
[TBL] [Abstract][Full Text] [Related]
49. Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study.
Kaul S; Nagaich U; Verma N
Drug Deliv Transl Res; 2022 Jul; 12(7):1719-1737. PubMed ID: 34582029
[TBL] [Abstract][Full Text] [Related]
50. Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.
Jha RK; Tiwari S; Mishra B
AAPS PharmSciTech; 2011 Jun; 12(2):650-7. PubMed ID: 21562721
[TBL] [Abstract][Full Text] [Related]
51. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
52. Formulation Design, Optimization and Pharmacodynamic Evaluation of Sustained Release Mucoadhesive Microcapsules of Venlafaxine HCl.
Swain S; Behera A; Dinda SC; Patra CN; Jammula S; Beg S; Rao ME
Indian J Pharm Sci; 2014 Jul; 76(4):354-63. PubMed ID: 25284934
[TBL] [Abstract][Full Text] [Related]
53. Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
Ch S; Padaga SG; Ghosh B; Roy S; Biswas S
Carbohydr Polym; 2023 Jul; 312():120822. PubMed ID: 37059521
[TBL] [Abstract][Full Text] [Related]
54. Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits.
Shah J; Nair AB; Jacob S; Patel RK; Shah H; Shehata TM; Morsy MA
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083593
[TBL] [Abstract][Full Text] [Related]
55. Linum usitatissimum seed mucilage-alginate mucoadhesive microspheres of metformin HCl: Fabrication, characterization and evaluation.
Ghumman SA; Noreen S; Tul Muntaha S
Int J Biol Macromol; 2020 Jul; 155():358-368. PubMed ID: 32224187
[TBL] [Abstract][Full Text] [Related]
56. Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
Gade SK; Nirmal J; Garg P; Venuganti VVK
Int J Pharm; 2020 Dec; 591():120023. PubMed ID: 33127488
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
58. A New Topical Eye Drop Containing LyeTxI-b, A Synthetic Peptide Designed from A
Silva CND; Silva FRD; Dourado LFN; Reis PVMD; Silva RO; Costa BLD; Nunes PS; Amaral FA; Santos VLD; de Lima ME; Silva Cunha Júnior AD
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30987317
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery.
Kanoujia J; Kushwaha PS; Saraf SA
Drug Deliv Transl Res; 2014 Aug; 4(4):334-43. PubMed ID: 25787066
[TBL] [Abstract][Full Text] [Related]
60. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
Chawla A; Sharma P; Pawar P
Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
